CTI Life Sciences Fund Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 4
Professionals
  • Investments
  • 34
  • Portfolio
  • 7
  • Exits
  • 16
Exits

CTI Life Sciences Fund General Information

Description

Founded in 2006 CTI Life Sciences Fund is a venture capital investment firm that is based in Montreal, Canada. The firm prefers to invest in the life sciences and healthcare companies at the pre-clinical and clinical development stages located in the United States and Canada.

Contact Information

Year Founded
2006
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 1 Place Ville-Marie
  • Bureau 1050
  • Montreal, Quebec H3B 4S6
  • Canada
+1 (514) 000-0000

CTI Life Sciences Fund Investments (34)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Phenomic AI 15-Jun-2020 Seed Round 000 Discovery Tools (Healthcare) Generating Revenue 000000000 000000 00.0
0000 000000000000 08-Jun-2020 00000 00000 Drug Discovery Generating Revenue 00000000 0000000 00.0
0000000 26-Mar-2020 00000 00000 00000 Drug Discovery Startup
0000000 19-May-2018 00000 00000 0000 Drug Discovery Startup
00000000 05-Oct-2017 00000 00000 000.00 Biotechnology Generating Revenue
0000000000 27-Jul-2017 00000 00000 0000 Biotechnology Startup 00000000 0000000 00.0
00000 0000000 27-Jun-2017 00000 00000 0000 Software Development Applications Generating Revenue 000000000 000000 00.0
0000000 21-Mar-2017 00000 00000 0000 Drug Discovery Startup
CellAegis Devices 10-Mar-2017 Later Stage VC 00.00 Therapeutic Devices Generating Revenue 000000000 000000 00.0
Ilkos Therapeutic 26-Sep-2016 Seed Round 0000 Drug Discovery Generating Revenue 0000-00000000 00000000
You’re viewing 10 of 34 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CTI Life Sciences Fund Exits (16)

Company Name Exit Date Exit Type Exit Size
Ilkos Therapeutic 30-Dec-2020 Merger/Acquisition
00000000 0000000 21-Jul-2020 000000 0000000000 000.00
0000000 12-Jun-2020 000 00000
000000000 09-Oct-2018 000000000000000000
00000000 31-Aug-2018 000000000000000000 00000
00000 000000000000 01-Mar-2018 000 00 00000000
0000000 25-Jan-2018 000000000000000000
0000000 28-Sep-2017 0000000000: 000000
Zymeworks 28-Apr-2017 IPO 0000
Somnus Therapeutics 01-Jan-2016 Out of Business
You’re viewing 10 of 16 exits. Get the full list »

CTI Life Sciences Fund Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

CTI Life Sciences Fund Team (6)

Name Title Deals Funds Boards Office
Jean-Francois Leprince Managing Partner 0 0 0 Montreal, Canada
Shermaine Tilley Ph.D Managing Partner 00 0 0 Montreal, Canada
Ken Pastor General Partner & Founder 0 Montreal, Canada
Laurence Rulleau Ph.D Partner & Principal 0 0 0 Montreal, Canada
You’re viewing 4 of 6 team members. Get the full list »

CTI Life Sciences Fund Co-Investors (46)

Name With Exits Lead Partner Series Industry
Abingworth Management 1 0 Series chart Industry bar
Allegheny Financial Group 0 0 Series chart Industry bar
Frazier Healthcare Partners 0 0 Series chart Industry bar
Lux Capital Management 0 0 Series chart Industry bar
TPG 0 Series chart Industry bar
You’re viewing 5 of 46 co-investors. Get the full list »